Why It Matters
Unum Group disclosed lobbying in the third quarter of 2026 on the implementation of the McCarran-Ferguson antitrust repeal for insurers, focusing on its impact on employer-provided benefits and the supplemental and voluntary benefits insurance industry. The McCarran-Ferguson Act generally limits federal antitrust law's application to the business of insurance when states regulate it, but the Competitive Health Insurance Reform Act of 2020 restored federal antitrust application to health insurance.
By the Numbers
Unum Group's third-quarter 2026 filing reports $170,000 in lobbying expenditures, unchanged from its own in-house report last quarter. The combined client total for the second quarter of 2026 was $200,000, which included a $30,000 filing from Kountoupes Denham Carr & Reid LLC.
The filing lists one lobbyist: Marty McGuinness, vice president and head of government affairs, whose record lists prior government experience, including a member's office with Rep. Pete Sessions (R-TX-17) and Rules Committee (House) experience in the 106th and 107th Congresses.
Broader Context
The McCarran-Ferguson Act generally limits federal antitrust law's application to the business of insurance when states regulate it. The Competitive Health Insurance Reform Act of 2020 narrowed that framework, restoring federal antitrust oversight of health insurance while leaving the broader McCarran-Ferguson structure intact. The debate now centers on whether to extend similar treatment to other lines, including the employer-provided and supplemental benefits markets Unum Group's filing names.
The Bottom Line
Unum Group's in-house spending varied across recent quarters, ranging from $150,000 to $230,000.
Access the Legis1 platform for comprehensive political news, data, and insights
Spot something wrong? Report an issue with this article
